Whole-lesion histogram and texture analyses of breast lesions on inline quantitative DCE mapping with CAIPIRINHA-Dixon-TWIST-VIBE
暂无分享,去创建一个
Robert Grimm | Kun Sun | Dominik Nickel | Caixia Fu | Weimin Chai | Fuhua Yan | R. Grimm | W. Chai | Fuhua Yan | K. Sun | Hong Zhu | Y. Zhan | D. Nickel | C. Fu | Hong Zhu | Ying Zhan
[1] Dukyong Yoon,et al. Is there any correlation between model-based perfusion parameters and model-free parameters of time-signal intensity curve on dynamic contrast enhanced MRI in breast cancer patients? , 2014, European Radiology.
[2] M. Knopp,et al. Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.
[3] Gustav Andreisek,et al. Delayed gadolinium-enhanced MR imaging of articular cartilage: three-dimensional T1 mapping with variable flip angles and B1 correction. , 2009, Radiology.
[4] Hans-Peter Sinn,et al. A Brief Overview of the WHO Classification of Breast Tumors, 4th Edition, Focusing on Issues and Updates from the 3rd Edition , 2013, Breast Care.
[5] I. Kamel,et al. Improved Detection of Recurrent Hepatocellular Carcinomas in Arterial Phase With CAIPIRINHA-Dixon-TWIST-Volumetric Interpolated Breath-Hold Examination , 2016, Investigative radiology.
[6] CAIPIRINHA-Dixon-TWIST (CDT)-VIBE MR imaging of the liver at 3.0T with gadoxetate disodium: a solution for transient arterial-phase respiratory motion-related artifacts? , 2018, European Radiology.
[7] A. Jemal,et al. Cancer statistics, 2019 , 2019, CA: a cancer journal for clinicians.
[8] Yajia Gu,et al. Feasibility study of dual parametric 2D histogram analysis of breast lesions with dynamic contrast-enhanced and diffusion-weighted MRI , 2018, Journal of Translational Medicine.
[9] Walter H Backes,et al. The precision of pharmacokinetic parameters in dynamic contrast-enhanced magnetic resonance imaging: the effect of sampling frequency and duration , 2011, Physics in medicine and biology.
[10] R. Lerski,et al. Interim heterogeneity changes measured using entropy texture features on T2-weighted MRI at 3.0 T are associated with pathological response to neoadjuvant chemotherapy in primary breast cancer , 2017, European Radiology.
[11] N. Harbeck. Insights into biology of luminal HER2 vs. enriched HER2 subtypes: Therapeutic implications. , 2015, Breast.
[12] Jin You Kim,et al. Dynamic contrast‐enhanced and diffusion‐weighted MRI of estrogen receptor‐positive invasive breast cancers: Associations between quantitative MR parameters and Ki‐67 proliferation status , 2017, Journal of magnetic resonance imaging : JMRI.
[13] Lihua Li,et al. Differentiation of triple-negative breast cancer from other subtypes through whole-tumor histogram analysis on multiparametric MR imaging , 2018, European Radiology.
[14] Thierry Metens,et al. Quantitative DCE-MRI for prediction of pathological complete response following neoadjuvant treatment for locally advanced breast cancer: the impact of breast cancer subtypes on the diagnostic accuracy , 2016, European Radiology.
[15] Kyunghyun Sung,et al. Transmit B1+ field inhomogeneity and T1 estimation errors in breast DCE‐MRI at 3 tesla , 2013, Journal of magnetic resonance imaging : JMRI.
[16] Glen R Morrell,et al. Pharmacokinetic mapping for lesion classification in dynamic breast MRI , 2010, Journal of magnetic resonance imaging : JMRI.
[17] C. Schraml,et al. Feasibility of CAIPIRINHA-Dixon-TWIST-VIBE for dynamic contrast-enhanced MRI of the prostate. , 2015, European journal of radiology.
[18] Karel G M Moons,et al. Meta-analysis of MR imaging in the diagnosis of breast lesions. , 2008, Radiology.
[19] Lindsay W. Turnbull,et al. Prognostic value of DCE-MRI in breast cancer patients undergoing neoadjuvant chemotherapy: a comparison with traditional survival indicators , 2014, European Radiology.
[20] G. Wright,et al. Rapid high‐resolution T1 mapping by variable flip angles: Accurate and precise measurements in the presence of radiofrequency field inhomogeneity , 2006, Magnetic resonance in medicine.
[21] Tao Ai,et al. Application of whole‐lesion histogram analysis of pharmacokinetic parameters in dynamic contrast‐enhanced MRI of breast lesions with the CAIPIRINHA‐Dixon‐TWIST‐VIBE technique , 2018, Journal of magnetic resonance imaging : JMRI.
[22] Thomas E Yankeelov,et al. A novel AIF tracking method and comparison of DCE-MRI parameters using individual and population-based AIFs in human breast cancer , 2011, Physics in medicine and biology.
[23] M. Cheang,et al. Prognostic Value of Intrinsic Subtypes in Hormone Receptor-Positive Metastatic Breast Cancer Treated With Letrozole With or Without Lapatinib. , 2016, JAMA oncology.
[24] V. Jellús,et al. Variable flip angle‐based fast three‐dimensional T1 mapping for delayed gadolinium‐enhanced MRI of cartilage of the knee: Need for B1 correction , 2011, Magnetic resonance in medicine.
[25] Guangbin Wang,et al. Influence of scan duration on the estimation of pharmacokinetic parameters for breast lesions: a study based on CAIPIRINHA-Dixon-TWIST-VIBE technique , 2015, European Radiology.
[26] R. A. Lerski,et al. Magnetic resonance imaging texture analysis classification of primary breast cancer , 2016, European Radiology.
[27] Wei Huang,et al. Discrimination of benign and malignant breast lesions by using shutter-speed dynamic contrast-enhanced MR imaging. , 2011, Radiology.
[28] Piotr Kozlowski,et al. Comparison between population average and experimentally measured arterial input function in predicting biopsy results in prostate cancer. , 2010, Academic radiology.
[29] Eun Sook Ko,et al. Breast cancer heterogeneity: MR Imaging Texture Analysis and Survival Outcomes1 , 2016 .
[30] E. Rostrup,et al. Measurement of the arterial concentration of Gd‐DTPA using MRI: A step toward quantitative perfusion imaging , 1996, Magnetic resonance in medicine.
[31] Woo Kyung Moon,et al. Early Prediction of Response to Neoadjuvant Chemotherapy Using Parametric Response , 2015 .